Central Nervous System News and Research

RSS

Transplantation of bone marrow-derived EPCs slows ALS disease progression

Transplantation of human bone marrow-derived endothelial progenitor cells into mice mimicking symptoms of amyotrophic lateral sclerosis (ALS) helped mor, University of South Florida researchers report.

3 Apr 2019

Gastrointestinal symptoms in children could be a red flag for future mental health problems

A Columbia University study has found that adversity early in life is associated with increased gastrointestinal symptoms in children that may have an impact on the brain and behavior as they grow to maturity.

29 Mar 2019

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease.

29 Mar 2019

Study shows link between maternal diet during pregnancy and risk of ADHD symptoms in children

The results of a study led by a team from the Barcelona Institute for Global Health, a center supported by "la Caixa", suggest that the risk of a child developing symptoms of attention deficit hyperactivity disorder (ADHD) may be modulated by the mother's diet during pregnancy.

28 Mar 2019

Study finds no damaging role for microglia during retinal prion disease in mice

National Institutes of Health scientists studying the progression of inherited and infectious eye diseases that can cause blindness have found that microglia, a type of nervous system cell suspected to cause retinal damage, surprisingly had no damaging role during prion disease in mice.

28 Mar 2019

FDA approves new drug to treat adults with relapsing forms of MS

The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

27 Mar 2019

Enamine and Lundbeck announce expansion of drug discovery collaboration

Enamine and H. Lundbeck today announced the expansion of their research collaboration.

From Enamine Ltd 26 Mar 2019

Cardiff University launches Medicines Discovery Institute to develop new generation of drugs

Cardiff University is stepping up the development of new drugs for mental health and central nervous system conditions, with the launch of the Medicines Discovery Institute.

25 Mar 2019

Nervous system relies on guidance cues for neuronal axons to reach destinations

Similar to the dozens of Sherpas that guide hikers up treacherous Himalayan mountains to reach a summit, the nervous system relies on elaborate timing and location of guidance cues for neuronal axons--threadlike projections--to successfully reach their destinations in the body.

25 Mar 2019

Butler Hospital receives COBRE grant to enhance research on neuropsychiatric illnesses

Neuropsychiatric illnesses are common and highly impairing conditions that arise from abnormal functioning of the brain.

21 Mar 2019

Scientists grow most sophisticated brain organoid to date

Researchers at Cambridge Biomedical Campus have grown the most sophisticated brain organoid to date, providing new opportunities for scientists to understand human brain development and neurological disorders.

20 Mar 2019

Study identifies gene variant associated with accelerated cellular aging

It is well known that psychiatric stress is associated with accelerated aging. Now, a new study shows that a gene mutation interacts with multiple types of psychiatric stress including post-traumatic stress disorder (PTSD), pain and sleep disturbances in association with cellular aging.

20 Mar 2019

Miniature brains that can move muscles, grown in the lab

Researchers have successfully created miniature organoid brains in the labs that when attached to a spinal cord and muscles could help move the muscles.

19 Mar 2019

New case study describes adolescent patient with rapid-onset schizophrenia and Bartonella infection

In a new case study, researchers at North Carolina State University describe an adolescent human patient diagnosed with rapid onset schizophrenia who was found instead to have a Bartonella henselae infection.

19 Mar 2019

Fingermark imaging for identification of drugs

In a paper to be published in the forthcoming issue in NANO, researchers from Zhejiang have uncovered a novel method of using nanocarrier-based biological fluorescent probes for detecting amphetamine and ketamine in latent fingermark, in a bid to combat drug abuse.

15 Mar 2019

Study: More vitamin D may boost memory but too much could lead to slower reaction time

How much vitamin D can boost memory, learning and decision-making in older adults, and how much is too much?

15 Mar 2019

Research team identifies potential target protein aggregates for treating Alzheimer's disease

The aggregation of alpha-synuclein proteins in Parkinson's disease and tau proteins in Alzheimer's disease is intimately linked to the progression of these neurodegenerative diseases. These aggregates propagate from one neuronal cell to another, attaching themselves to the cells.

8 Mar 2019

Radiation after surgery in children with ependymoma nearly triples survival rate

Radiation immediately following surgery in children with ependymoma, the third most common pediatric brain tumor, can nearly triple survival.

5 Mar 2019

Researchers discover mechanism for how male sex steroids sculpt brain development

Researchers at the University of Maryland School of Medicine have discovered a mechanism for how androgens -- male sex steroids -- sculpt brain development. The research, conducted by Margaret M. McCarthy, Ph.D., who Chairs the Department of Pharmacology, could ultimately help researchers understand behavioral development differences between males and females.

4 Mar 2019

Research reveals how metabolites can be used to inhibit epigenetic mechanisms and treat MS

Understanding and mitigating the role of epigenetics (environmental influences that trigger changes in gene expression) in disease development is a major goal of researchers.

28 Feb 2019